16.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVCR Giù?
Forum
Previsione
Precedente Chiudi:
$17.00
Aprire:
$17.32
Volume 24 ore:
467.66K
Relative Volume:
0.48
Capitalizzazione di mercato:
$1.90B
Reddito:
$577.74M
Utile/perdita netta:
$-149.78M
Rapporto P/E:
-12.09
EPS:
-1.4
Flusso di cassa netto:
$-78.21M
1 W Prestazione:
-0.47%
1M Prestazione:
-2.42%
6M Prestazione:
-40.80%
1 anno Prestazione:
-21.12%
Novocure Ltd Stock (NVCR) Company Profile
Nome
Novocure Ltd
Settore
Industria
Telefono
44 (0)15 3475 6700
Indirizzo
NO. 4 THE FORUM, ST. HELIER
Confronta NVCR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NVCR
Novocure Ltd
|
16.94 | 1.90B | 577.74M | -149.78M | -78.21M | -1.40 |
![]()
ABT
Abbott Laboratories
|
133.75 | 232.39B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
100.99 | 154.11B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
382.64 | 145.55B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.62 | 107.35B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.54 | 45.81B | 5.54B | 4.18B | 623.10M | 7.00 |
Novocure Ltd Stock (NVCR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
2024-10-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2023-11-20 | Ripresa | JP Morgan | Neutral |
2023-08-28 | Downgrade | H.C. Wainwright | Buy → Neutral |
2023-08-08 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2023-08-04 | Iniziato | SVB Securities | Outperform |
2023-07-31 | Aggiornamento | Evercore ISI | Underperform → In-line |
2023-06-07 | Aggiornamento | Wedbush | Underperform → Neutral |
2023-05-16 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-03-17 | Downgrade | JP Morgan | Neutral → Underweight |
2023-01-06 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2023-01-05 | Reiterato | H.C. Wainwright | Buy |
2022-11-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2022-10-24 | Downgrade | Piper Sandler | Overweight → Neutral |
2022-07-05 | Downgrade | Evercore ISI | In-line → Underperform |
2022-05-16 | Iniziato | H.C. Wainwright | Buy |
2022-02-08 | Iniziato | Loop Capital | Buy |
2022-02-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
2022-01-20 | Aggiornamento | Truist | Hold → Buy |
2022-01-03 | Aggiornamento | Evercore ISI | Underperform → In-line |
2021-07-01 | Downgrade | Mizuho | Buy → Neutral |
2021-04-14 | Downgrade | Wedbush | Neutral → Underperform |
2021-01-25 | Reiterato | Piper Sandler | Overweight |
2020-09-23 | Iniziato | Northland Capital | Outperform |
2020-09-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2020-09-17 | Downgrade | Truist | Buy → Hold |
2020-06-01 | Ripresa | Oppenheimer | Perform |
2020-05-01 | Downgrade | Oppenheimer | Outperform → Perform |
2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
2020-03-05 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
2019-07-29 | Aggiornamento | SunTrust | Hold → Buy |
2019-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
2019-07-26 | Downgrade | Wedbush | Outperform → Neutral |
2019-03-20 | Iniziato | SunTrust | Hold |
2018-11-02 | Downgrade | Wells Fargo | Outperform → Market Perform |
2018-07-16 | Iniziato | Evercore ISI | Outperform |
2018-04-18 | Reiterato | Mizuho | Buy |
2018-02-23 | Reiterato | Mizuho | Buy |
2017-05-24 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
2016-07-29 | Reiterato | Wedbush | Outperform |
2016-01-19 | Iniziato | Barclays | Underweight |
2015-12-02 | Iniziato | Deutsche Bank | Hold |
Mostra tutto
Novocure Ltd Borsa (NVCR) Ultime notizie
NovoCure Ltd (NVCR) Shares Up 4.08% on Jun 6 - GuruFocus
NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial - TradingView
Mackenzie Financial Corp Purchases Shares of 6,820 NovoCure Limited (NASDAQ:NVCR) - Defense World
Novocure at Jefferies Conference: Expanding Horizons in Cancer Treatment - Investing.com
Insider Sell Alert: Frank Leonard Sells 30,196 Shares of NovoCure Ltd (NVCR) - GuruFocus
NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Ameriprise Financial Inc. Has $682,000 Position in NovoCure Limited (NASDAQ:NVCR) - Defense World
H.C. Wainwright reiterates Buy rating on NovoCure stock after ASCO data - Investing.com Nigeria
NovoCure Ltd (NVCR) Shares Down 7.43% on Jun 2 - GuruFocus
NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial - Benzinga
Novocure (NVCR) Gains Support for Future Launch from Promising Trial Outcomes | NVCR Stock News - GuruFocus
H.C. Wainwright reiterates Buy rating on NovoCure stock after ASCO data By Investing.com - Investing.com South Africa
Novocure (NVCR) Announces Positive Phase 3 Trial Results for Pancreatic Cancer Therapy | NVCR Stock News - GuruFocus
Novocure announces results from Phase 3 PANOVA-3 trial - TipRanks
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 - GuruFocus
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Lelezard
Results From the Phase 3 PANOVA-3 Trial of Novocure's Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | NVCR Stock News - GuruFocus
Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Yahoo Finance
NovoCure Ltd (NVCR) Shares Gap Down to $18.5801 on May 30 - GuruFocus
Nuveen Asset Management LLC Lowers Position in NovoCure Limited (NASDAQ:NVCR) - Defense World
1 Stock Down 35% This Year You'll Regret Not Buying on the Dip, According to Wall Street - AOL.com
Novocure Announces Upcoming Investor Events | NVCR Stock News - GuruFocus
Novocure Announces Upcoming Investor Events - Yahoo Finance
Is NovoCure (NASDAQ:NVCR) Using Debt Sensibly? - simplywall.st
BNP Paribas Financial Markets Sells 147,371 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
Dimensional Fund Advisors LP Sells 3,016 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
Does NovoCure (NVCR) Have the Potential to Rally 105.5% as Wall Street Analysts Expect? - Yahoo Finance
Tower Research Capital LLC TRC Sells 6,669 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
Raymond James Financial Inc. Purchases Shares of 11,672 NovoCure Limited (NASDAQ:NVCR) - Defense World
Investor Network: Novocure Ltd. to Host Earnings Call - ACCESS Newswire
NovoCure Limited (NASDAQ:NVCR) Given Average Rating of “Moderate Buy” by Analysts - Defense World
NovoCure Ltd (NVCR)’s Market Momentum: Closing Strong at 20.62, Down -3.28 - DWinneX
Envestnet Asset Management Inc. Buys New Holdings in NovoCure Limited (NASDAQ:NVCR) - Defense World
Mariner LLC Acquires Shares of 8,631 NovoCure Limited (NASDAQ:NVCR) - Defense World
Comparing Meihua International Medical Technologies (NASDAQ:MHUA) & NovoCure (NASDAQ:NVCR) - Defense World
Ratio Analysis: Unpacking NovoCure Ltd (NVCR)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
A year in review: NovoCure Ltd (NVCR)’s performance in the last year - uspostnews.com
Wall Street Analysts See a 91.92% Upside in NovoCure (NVCR): Can the Stock Really Move This High? - Yahoo Finance
NovoCure Ltd’s latest rating changes from various analysts - knoxdaily.com
What is NovoCure Ltd (NVCR) Stock Return on Shareholders’ Capital? - Sete News
Russell Investments Group Ltd. Sells 2,135 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
NovoCure First Quarter 2025 Earnings: Beats Expectations - simplywall.st
H.C. Wainwright maintains Buy on NovoCure, $38 price target By Investing.com - Investing.com Canada
NovoCure Ltd [NVCR] Shares Jump Approximately 56.80% Over the Year - knoxdaily.com
Why NovoCure Stock Skyrocketed This Week - Yahoo Finance
H.C. Wainwright maintains Buy on NovoCure, $38 price target - Investing.com
NovoCure Limited (NASDAQ:NVCR) Q1 2025 Earnings Call Transcript - Insider Monkey
NovoCure (NASDAQ:NVCR) Cut to “Sell” at StockNews.com - Defense World
NovoCure (NASDAQ:NVCR) Shares Gap Up After Earnings Beat - Defense World
NovoCure: Q1 Earnings Snapshot - Huron Daily Tribune
Bank of Montreal Can Buys New Position in NovoCure Limited (NASDAQ:NVCR) - Defense World
Novocure Ltd Azioni (NVCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Novocure Ltd Azioni (NVCR) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
LEUNG GABRIEL | Director |
Jun 03 '25 |
Sale |
17.31 |
999 |
17,297 |
81,229 |
Madden Martin J. | Director |
Jun 03 '25 |
Sale |
17.19 |
999 |
17,176 |
18,674 |
Scannell Timothy J | Director |
Jun 03 '25 |
Sale |
17.32 |
999 |
17,299 |
6,018 |
HILLEMAN JERYL L | Director |
Jun 03 '25 |
Sale |
17.26 |
999 |
17,247 |
5,591 |
Ocean Allyson J | Director |
Jun 03 '25 |
Sale |
17.29 |
999 |
17,269 |
3,054 |
VERNON W ANTHONY | Director |
Jun 03 '25 |
Sale |
17.35 |
999 |
17,329 |
167,887 |
Hung David | Director |
Jun 03 '25 |
Sale |
17.30 |
999 |
17,280 |
12,195 |
Leonard Frank X | EVP, Pres., Novocure Oncology |
Jun 02 '25 |
Sale |
17.50 |
30,196 |
528,413 |
168,452 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):